buthionine sulfoximine and glutathione depletion Iron-based metal-organic framework co-loaded with oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Disturbing the Redox Balance Using
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE Buthionine sulfoximine (BSO) depletes Jurkat T cell of GSH. Jurkat T Download Scientific Diagram D,L Buthionine sulfoximine CAS 83730 53 4 Focus Biomolecules Effects of ATO and or BSO on GSH depletion and viability in A549 cells. Download Scientific Diagram
Pay in 4 interest-free payments of $5.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



